Imports and Exports of Synthetic Opioid Restricted
The Drug Enforcement Administration has issued a final order that temporarily schedules the synthetic opioid 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (also known as U-47700) and its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act.
As a result, this substance is subject to the regulatory controls and administrative, civil, and criminal sanctions applicable to the manufacture, distribution, reverse distribution, importation, exportation, research, conduct of instructional activities and chemical analysis, and possession of schedule I controlled substances. This order is effective Nov. 14 and will be in effect for two years, with a possible extension of one year, pending completion of the permanent scheduling process.
According to the DEA, available data and information indicate that U-47700 has a high potential for abuse, no currently accepted medical use in treatment in the U.S., and a lack of accepted safety for use under medical supervision.